- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NTLA
Recent news which mentions NTLA
3 Gene Editing Stocks With Unprecedented Surge Potential
February 13, 2024
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
From InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
February 07, 2024
From Motley Fool
Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock
February 05, 2024
From Benzinga
A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist
February 05, 2024
From Motley Fool
Cathie Wood's Ark Invest Snatches Up $4.7M More In Tesla Shares, Invests Equally In This Rocket Company
February 01, 2024
From Benzinga
From InvestorPlace
History Says the S&P 500 May Climb in the Triple Digits During This Bull Market. 3 Top Growth Stocks to Buy Before it Does.
January 30, 2024
From Motley Fool
2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street
January 27, 2024
From Motley Fool
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
January 22, 2024
From InvestorPlace
Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics
January 21, 2024
From Motley Fool
The Top Healthcare Stocks to Buy With $100
January 13, 2024
From Motley Fool
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
January 08, 2024
From Motley Fool
From Motley Fool
AlloVir Layoffs 2024: What to Know About the Latest ALVR Job Cuts
January 05, 2024
From InvestorPlace
Why Is Medical Properties Trust (MPW) Stock Down 31% Today?
January 05, 2024
From InvestorPlace
From InvestorPlace
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
From Motley Fool
5 Beaten-Down Stocks That Could Soar in 2024
December 16, 2023
From Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
From InvestorPlace
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?
December 12, 2023
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
November 28, 2023
From Motley Fool
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 20, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
From Benzinga
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
November 13, 2023
From Benzinga
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.